Botulinum toxin type A injections for myofascial pain syndrome and tension-type headache

被引:20
|
作者
Porta, M [1 ]
机构
[1] Policlin San Marco, Dept Neurol, Pain Ctr, I-24040 Zingonia Bergamo, Italy
关键词
myofascial pain syndrome; tension-type headache; botulinum toxin; pain; muscle relaxant;
D O I
10.1111/j.1468-1331.1999.tb00025.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Myofascial pain syndrome (MPS) is characterised by acute and specific pain affecting the piriformis, iliopsoas or scalenus anterior muscles. Tension-type headache (TH) is a common pathological condition, which can be chronic or episodic. Based on its muscle-relaxant properties, botulinum toxin type A (BTX-A) has demonstrated efficacy in a variety of conditions involving dysregulated muscle contractions. Patients with MPS (n = 40) or TH (n = 20) were recruited to two randomised, single-blind studies, respectively, Each patient received either BTX-A or methylprednisolone, injected into the affected muscles after administration of a local anaesthetic. Pain was assessed at baseline, and 30 and 60 days post-treatment using a standard visual analogue scale. At 30 days post-injection, the mean pain score in all treatment groups was reduced compared with baseline in both studies, although the difference between treatment groups was not significant at this time in either study. However, by 60 days post-injection, the mean pain score has continued to fall in the BTX-A treatment groups, compared with a waning of the steroid therapeutic activity in the controls. The net effect was a highly significant difference between the two treatments in both the MPS (P < 0.0001) and TH (P < 0.0005) studies. No major adverse events were reported. In conclusion, BTX-A produces a more prolonged pain relief than methylprednisolone in patients suffering from MPS or TH. Eur J Neurol 6 (suppl 4):S103-S109 (C) Lippincott Williams & Wilkins.
引用
收藏
页码:S103 / S109
页数:7
相关论文
共 50 条
  • [31] The efficiency of botulinum toxin type A for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache
    Malgorzata Pihut
    Ewa Ferendiuk
    Michal Szewczyk
    Katarzyna Kasprzyk
    Mieszko Wieckiewicz
    The Journal of Headache and Pain, 2016, 17
  • [32] Myofascial trigger points and sensitization:: an updated pain model for tension-type headache
    Fernandez-de-las-Penas, C.
    Cuadrado, M. L.
    Arendt-Nielsen, L.
    Simons, D. G.
    Pareja, J. A.
    CEPHALALGIA, 2007, 27 (05) : 383 - 393
  • [33] Botulinum toxin a is effective to treat tension-type headache caused by hemifacial spasm
    Mizuma, A.
    Nagata, E.
    Yasuda, T.
    Kouchi, M.
    Nakayama, T.
    Honma, K.
    Tokuoka, K.
    Kitagawa, Y.
    Nogawa, S.
    Takizawa, S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 940 - 940
  • [34] Botulinum toxin A is effective to treat tension-type headache caused by hemifacial spasm
    Mizuma, Atsushi
    Nagata, Eiichiro
    Yasuda, Takashi
    Kouchi, Maiko
    Nakayama, Taira
    Honma, Kazunari
    Tokuoka, Kentaro
    Kitagawa, Yasuhisa
    Nogawa, Shigeru
    Takizawa, Shunya
    JOURNAL OF CLINICAL NEUROSCIENCE, 2017, 44 : 284 - 288
  • [35] Botulinum toxin type A therapy for chronic tension-type headache: Fact versus fiction - Response
    Schulte-Mattler, WJ
    Krack, P
    PAIN, 2005, 116 (1-2) : 167 - 167
  • [36] Evidence-based medicine: botulinum toxin A in migraine and tension-type headache
    H. Göbel
    A. Heinze
    K. Heinze-Kuhn
    W. H. Jost
    Journal of Neurology, 2001, 248 (Suppl 1) : I34 - I38
  • [37] Evidence-based medicine:: botulinum toxin A in migraine and tension-type headache
    Göbel, H
    Heinze, A
    Heinze-Kuhn, K
    Jost, WH
    JOURNAL OF NEUROLOGY, 2001, 248 : S34 - S38
  • [38] Myofascial trigger points in migraine and tension-type headache
    Thien Phu Do
    Gerda Ferja Heldarskard
    Lærke Tørring Kolding
    Jeppe Hvedstrup
    Henrik Winther Schytz
    The Journal of Headache and Pain, 2018, 19
  • [39] Myofascial trigger points in migraine and tension-type headache
    Thien Phu Do
    Heldarskard, Gerda Ferja
    Kolding, Laerke Torring
    Hvedstrup, Jeppe
    Schytz, Henrik Winther
    JOURNAL OF HEADACHE AND PAIN, 2018, 19 : 84
  • [40] Botulinum toxin (DYSPORT) in tension-type headaches
    Rollnik, JD
    Dengler, R
    FUNCTIONAL REHABILITATION IN NEUROSURGERY AND NEUROTRAUMATOLOGY, 2002, 79 : 123 - 126